Top 2 Health Care Stocks That May Plunge This Month

1. Esperion Therapeutics reported strong Q2 financial results, surpassing expectations. 2. Net U.S. product sales increased 42% year-over-year, reflecting commercial success. 3. The stock surged 56% over the past month, peaking at $3.94. 4. Current RSI value is 85.7, indicating overbought conditions. 5. Shares closed at $2.53, rising 4.1% recently.